{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:59:07Z","timestamp":1771261147564,"version":"3.50.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Facioscapulohumeral muscular dystrophy type 1 (FSHD1) and Becker muscular dystrophy (BMD) are distinct disorders caused by different genetic variations and exhibiting different inheritance patterns. The co-occurrence of both conditions within the same family is rare. In this case report, the proband was a 10\u00a0year-old boy who presented with eye and mouth orbicular muscles, shoulder and proximal upper and lower limbs weakness. Genetic testing showed that the number of D4Z4 repeat units in the sub-terminal region 4qA of chromosome 4q35 in the proband was only 4 (normal value \u2265 11) and, at the same time, a heterozygous deletion was found in exons 13\u201329 of <jats:italic>DMD<\/jats:italic> gene in the proband, thus the diagnosis was clinically and genetically compatible with both FSHD1 and BMD. Pedigree investigation revealed that his maternal grandmother, mother, aunt and cousin also had muscle weakness in the face, shoulders and limbs. Genetic testing confirmed that each of the four relatives had four D4Z4 repeats in the 4qA region, and all of them carried a heterozygous deletion in exons 13\u201329 of <jats:italic>DMD<\/jats:italic>. Based on the X-linked features of DMD\/BMD, the maternal grandmother, mother, and aunt were diagnosed with FSHD1 combined with <jats:italic>DMD<\/jats:italic> deletion carriers, and the male cousin was diagnosed with FSHD1 combined with BMD. This study identifies a family with a co-occurrence of clinically overt FSHD1 and BMD, which has important reference value for the diagnosis and treatment of hereditary myopathies.<\/jats:p>","DOI":"10.3389\/fgene.2024.1522203","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T07:39:15Z","timestamp":1736235555000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Facioscapulohumeral muscular dystrophy type 1 combined with becker muscular dystrophy: a family case report"],"prefix":"10.3389","volume":"15","author":[{"given":"Menglin","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyi","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieming","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e39903","DOI":"10.7759\/cureus.39903","article-title":"Treatment of facioscapulohumeral muscular dystrophy (FSHD): a systematic review","volume":"15","author":"Aguirre","year":"2023","journal-title":"Cureus J Med Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2350-13-73","article-title":"Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype","volume":"13","author":"Brioschi","year":"2012","journal-title":"BMC Med. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1093\/eurheartj\/ehac544.2624","article-title":"Assessment of left atrial function and diastolic dysfunction in patients with Becker muscular dystrophy","volume":"43","author":"Gegenava","year":"2022","journal-title":"Eur. Heart J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jns.2013.09.036","article-title":"Symptomatic female carriers of Duchenne muscular dystrophy (DMD): genetic and clinical characterization","volume":"336","author":"Giliberto","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"E378","DOI":"10.1212\/WNL.0000000000006819","article-title":"Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy","volume":"92","author":"Goselink","year":"2019","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ana.25326","article-title":"Facioscapulohumeral dystrophy in childhood: a nationwide natural history study","volume":"84","author":"Goselink","year":"2018","journal-title":"Ann. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0960-8966(94)00055-e","article-title":"DNA rearrangements in Japanese facioscapulohumeral muscular-dystrophy patients: clinical correlations","volume":"5","author":"Goto","year":"1995","journal-title":"Neuromuscul. Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.nmd.2016.03.001","article-title":"Clinical, muscle pathological, and genetic features of Japanese facioscapulohumeral muscular dystrophy 2 (FSHD2) patients with SMCHD1 mutations","volume":"26","author":"Hamanaka","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"E2441","DOI":"10.1212\/WNL.0000000000009617","article-title":"Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy","volume":"94","author":"Hamanaka","year":"2020","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s13311-018-00675-3","article-title":"Facioscapulohumeral muscular dystrophy: update on pathogenesis and future treatments","volume":"15","author":"Hamel","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0135189","DOI":"10.1371\/journal.pone.0135189","article-title":"DMD mutations in 576 dystrophinopathy families: a step forward in genotype-phenotype correlations","volume":"10","author":"Juan-Mateu","year":"2015","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.nmd.2006.06.008","article-title":"Severe phenotype in infantile facioscapulohumeral muscular dystrophy","volume":"16","author":"Klinge","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1086\/521986","article-title":"Specific sequence variations within the 4q35 region are associated with Facioscapulohumeral muscular dystrophy","volume":"81","author":"Lemmers","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/jmg.28.10.655","article-title":"Genetic counselling in facioscapulohumeral muscular dystrophy","volume":"28","author":"Lunt","year":"1991","journal-title":"J. Med. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1242\/bio.20121305","article-title":"Conditional over-expression of PITX1 causes skeletal muscle dystrophy in mice","volume":"1","author":"Pandey","year":"2012","journal-title":"Biol. Open"},{"key":"B20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.nmd.2008.06.387","article-title":"Becker's muscular dystrophy aggravating facioscapulohumeral muscular dystrophy - double trouble as an explanation for an atypical phenotype","volume":"18","author":"Rudnik-Sch\u00f6neborn","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ajhg.2013.08.004","article-title":"The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1","volume":"93","author":"Sacconi","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13018-022-02996-8","article-title":"Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis","volume":"17","author":"Salari","year":"2022","journal-title":"J. Orthop. Surg. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/jamacardio.2016.4801","article-title":"Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial","volume":"2","author":"Silva","year":"2017","journal-title":"Jama Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1212\/WNL.0000000000002217","article-title":"Milder phenotype in facioscapulohumeral dystrophy with 7-10 residual D4Z4 repeats","volume":"85","author":"Statland","year":"2015","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mus.20522","article-title":"Facioscapulohumeral muscular dystrophy","volume":"34","author":"Tawil","year":"2006","journal-title":"Muscle Nerve"},{"key":"B26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41582-022-00762-2","article-title":"Facioscapulohumeral muscular dystrophy: the road to targeted therapies","volume":"19","author":"Tihaya","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/humu.20976","article-title":"Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase","volume":"30","author":"Tuffery-Giraud","year":"2009","journal-title":"Hum. Mutat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","article-title":"Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of facioscapulohumeral dystrophy","volume":"98","author":"van den Boogaard","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/ng1262","article-title":"Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy","volume":"35","author":"van Overveld","year":"2003","journal-title":"Nat. Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/ng0992-26","article-title":"Chromosome-4q DNA rearrangements associated with facioscapulohumeral muscular-dystrophy","volume":"2","author":"Wijmenga","year":"1992","journal-title":"Nat. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"E444","DOI":"10.1212\/WNL.0000000000005915","article-title":"A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1","volume":"91","author":"Wohlgemuth","year":"2018","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e27907","DOI":"10.1097\/MD.0000000000027907","article-title":"A pediatric case report and literature review of facioscapulohumeral muscular dystrophy type1","volume":"100","author":"Xiao","year":"2021","journal-title":"Medicine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/(sici)1096-8628(19980501)77:2<155::aid-ajmg9>3.3.co;2-g","article-title":"The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females","volume":"77","author":"Zatz","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"B34","first-page":"99","article-title":"High proportion of new mutations and possible anticipation in brazilian facioscapulohumeral muscular-dystrophy families","volume":"56","author":"Zatz","year":"1995","journal-title":"Am. J. Hum. Genet."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1522203\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T07:39:19Z","timestamp":1736235559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1522203\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":34,"alternative-id":["10.3389\/fgene.2024.1522203"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2024.1522203","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"article-number":"1522203"}}